டெல்லா பாஸ்கா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டெல்லா பாஸ்கா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டெல்லா பாஸ்கா Today - Breaking & Trending Today

Novartis and GSK announce collaboration to support scientifi

ng
Therapeutics (GRADIENT), with a combined funding commitment of GBP 2.8 million (USD 3.6 million) over five years, calls on African researchers to submit robust research proposals on the relevance of African genetic diversity to the treatment of malaria and tuberculosis (TB).
1
Lutz Hegemann, M.D., Chief Operating Officer for Global Health at Novartis said: “Novartis has a long-standing commitment to improving and extending the lives of patients around the world. Our efforts include seeking innovative ways to improve the standard of care where possible. This is why we are excited by this important collaboration on scientific research on genetic diversity in Africa. It has the potential to improve the efficacy and tolerability of current and future medicines, starting with two of the most deadly diseases, malaria and tuberculosis. In alignment with our ongoing efforts to strengthen scientific capabilities in lower-resource settings, this project also provides op ....

United States , Isabella Zinck , Eric Althoff , Thomas Hungerbuehler , Kara Cournoyer , Glenda Gray , Samir Shah , Lutz Hegemann , Sloan Simpson , Katerina Kontzalis , Antonio Ligi , Pauline Williams , Novartis Global Health Corporate Responsibility , Global Health Pharma , Novartis Institutes For Biomedical Research , Novartis Institutes For Biomedical Research On African , Steering Committee , Global Health At Novartis , Global Health Cr Communications , Novartis Us External Communications , Novartis External Communications , Exchange Commission , Africa Medical Research Council , African Medical Research Council , Africa Genomic Research Approach For Diversity , Project Africa Genomic Research Approach ,

GSK and Novartis announce collaboration to support scientific research into genetic diversity in Africa

ng
Therapeutics (GRADIENT), with a combined funding commitment of GBP 2.8m (USD 3.6 million) over five years, calls on African researchers to submit robust research proposals on the relevance of African genetic diversity to the treatment of malaria and tuberculosis.
1
Pauline Williams, Senior Vice President Global Health Pharma at GSK said: “At GSK, human genetics is a core pillar of our R&D strategy. Genetic diversity is greater in Africa than in any other continental population resulting in some African patients having varying response to treatments. We are excited to launch Project Africa GRADIENT which aims to catalyse the best science in the continent to optimize treatment responses for malaria and tuberculosis, two infectious diseases that disproportionately affect African populations.” ....

United Kingdom , Nairobi Area , United States , City Of , Simon Moore , Thomas Hungerbuehler , Jeff Mclaughlin , Simon Steel , Danielle Smith , Glenda Gray , Samir Shah , Lutz Hegemann , Ben Agina , Antonio Ligi , Sarah Elton Farr , Isabella Zinck , Evan Berland , Eric Althoff , Kara Cournoyer , Omongiade Ehighebolo , James Dodwell , Cory Twining , Sloan Simpson , Katerina Kontzalis , Pauline Williams , Novartis Global Health Corporate Responsibility ,